Reducing time to viral suppression in Europe

Lancet HIV. 2024 Jul;11(7):e431-e433. doi: 10.1016/S2352-3018(24)00127-9. Epub 2024 May 30.

Authors

Lise Cuzin¹, Pascal Pugliese²

Affiliations

¹ Centre for Epidemiology and Research in Population Health, Toulouse University, INSERM UMR1295, Toulouse, France; Martinique University Hospital, Infectious and Tropical Diseases, F97200 Fort-de-France, Martinique. Electronic address: lise.cuzin@chu-martinique.fr.
² Pascal Pugliese, Corevih Paca-Est, Archet Hospital, Côte d'Azur University, Nice, France.

PMID: 38824938
DOI: 10.1016/S2352-3018(24)00127-9

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use
Europe / epidemiology
HIV Infections* / drug therapy
HIV Infections* / epidemiology
HIV Infections* / prevention & control
HIV Infections* / virology
Humans
Viral Load

Substances

Anti-HIV Agents